A New Stability-Indicating RP-HPLC Method for the Simultaneous Estimation of Remogliflozin and Teneligliptin in Bulk and Pharmaceutical Dosage Form
International Journal of Pharmaceutical Investigation · 11.06.2026 · 16 (3) · 1078-1089
DOI: 10.5530/ijpi.20260115 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Investigation, online erschienen am 11.06.2026. Verfasst von Badupula Sravan Kumar und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kumar, B. S., & Redamala, R. (2026). A New Stability-Indicating RP-HPLC Method for the Simultaneous Estimation of Remogliflozin and Teneligliptin in Bulk and Pharmaceutical Dosage Form. International Journal of Pharmaceutical Investigation, 16(3), 1078-1089. https://doi.org/10.5530/ijpi.20260115
Vancouver
Kumar BS, Redamala R. A New Stability-Indicating RP-HPLC Method for the Simultaneous Estimation of Remogliflozin and Teneligliptin in Bulk and Pharmaceutical Dosage Form. International Journal of Pharmaceutical Investigation. 2026;16(3):1078-1089. doi:10.5530/ijpi.20260115
BibTeX
@article{Kumar2026,
author = {Kumar, Badupula Sravan and Redamala, Roopa},
title = {A New Stability-Indicating RP-HPLC Method for the Simultaneous Estimation of Remogliflozin and Teneligliptin in Bulk and Pharmaceutical Dosage Form},
journal = {International Journal of Pharmaceutical Investigation},
year = {2026},
volume = {16},
number = {3},
pages = {1078--1089},
doi = {10.5530/ijpi.20260115}
}
EUVIMED